The Scientist
The ScientistContent by The Scientist

Survey Methodology
The Scientist | | 2 min read
Survey Methodology Related Articles Best Places to Work in Academia, 2007 Easy livin' at Dalhousie First-Timers Massachusetts General Hospital: View from the top Purdue pushes forward Ranking Tables Top 15 US Academic Institutions Top 10 International Academic Institutions Top 40 US Academic Institutions Best Countries for Academic Research Best Places to Work: Survey Findings PDF Survey Form: A web

Nominate the best laboratory Web sites
The Scientist | | 1 min read
Submit your nominations for The Scientist's Laboratory Web Site and Video Awards - poll closes Friday

The RNA Conductome
The Scientist | | 1 min read
The RNA Conductome What can we learn from the in-process encyclopedia of how non-protein-coding sequences exert genetic control? The Scientist Staff Over the years, scientists and drug companies seeking genetic control over biological systems have focused their attention on proteins. But that's only one part of the picture: Recently, scientists have been accumulating evidence that non-protein-coding sequences often play the role of conductor in the body's response: it'

Vote now for the Best Places to Work as a Postdoc
The Scientist | | 1 min read
Your thoughts about your workplace will help us rank the best postdoc institutions around the world

Do you automate?
The Scientist | | 1 min read
We want more input about how you automate in the lab -- help us shape a future article on the topic

Vote for your favorite life science blogs
The Scientist | | 6 min read
Have your say in compiling the first list of the most popular life science blogs as decided by you, the community

5 HIV Treatment Strategies
The Scientist | | 2 min read
5 HIV Treatment Strategies What the common cold virus, stem cells, and phylogeny can do to save the millions of people living with HIV. The Scientist Staff In 2006, 25 years after AIDS made its first appearance in the CDC's Morbidity and Mortality Weekly Report, an estimated 2.9 million people died of the illness. That same year, more than 4 million people were infected with HIV, joining the 35.2 million living with HIV/AIDS. Despite the dozens of approved treatments for th

How to resolve authorship disputes
The Scientist | | 1 min read
We've had a great response so far debating the fairness of authorship rules. Give us your recommendations for how to change or improve the system of authorship by Wednesday, September 26 to help shape an upcoming feature in our Careers section

Special feature: How should scientists sell science?
The Scientist | | 2 min read
Tell us whether you think researchers should change the way they communicate hot-button issues to the public

Last chance to vote for the Best Places to Work in Academia
The Scientist | | 2 min read
Add your voice to the poll and help us place your institution in the ranking. Survey closes Sept. 4

The subtle side of science
The Scientist | | 3 min read
The winners of a writing competition bring the stories of scientists to life

Vote now for the Best Places to Work in Academia
The Scientist | | 2 min read
Help us provide you with comparative information on the best academic institutions worldwide.

Does tenure need to change?
The Scientist | | 2 min read
We've had a great response to the debate on whether the current way of evaluating scientists is reasonable. Add your thoughts by Wednesday (July 25) and help shape our upcoming feature on the subject

Supplement: The Diseases
The Scientist | | 1 min read
The Diseases Autoimmunity is transformed from an esoteric scientific challenge by the daily reality of millions of patients. So we begin with a description of the impact of autoimmune disease on patients, their families, society and healthcare systems. The depth of the challenges that underlie autoimmune diseases come through in painfully clear ways in the series of patient profiles starting on the next page. As described by Stephen

Supplement: The Causes
The Scientist | | 1 min read
The Causes What causes autoimmune disease? Jeff Bluestone of the University of California, San Francisco - one of the world's leading authorities on the mechanisms behind autoimmunity - talks us through the pathways that trigger and fuel the internal battle to control the immune system. Thomas Dörner of the Charite University Hospital Berlin (see article here) and Yoshiyuki Ohsugi of Chugai Pharma












